Morphine Sulfate Orodispersible Tablets
Indication
Severe pain and breathlessness in patients with symptoms due to a palliative (life limiting) illness
Green (Restricted)
Brand:
(Actimorph®)
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Please note: there may be occasions where an active decision is taken to use Actimorph tablets in preference to liquid formulations when diversion of morphine liquid is suspected or confirmed.
Recommendation
LSCMMG Recommendation:
Green (Restricted)
Reason for decision:
Suitable for initiation in primary care in line with restrictions
Supporting documents: